CoagulationDisorders near Riverview, FL

Care Philosophy: At Florida Cancer Specialists & Research Institute you will find experienced and compassionate doctors you can trust to treat your unique cancer. Our physicians share a passion for delivering exceptional and personalized care for all forms of cancer and blood disorders, close to home. From genetic screening to immunotherapies and access to clinical trials, our top-ranked cancer experts provide the newest and most advanced treatments available increasing cure rates and extending lives. No other community-based oncology practice in Florida matches the clinical trial opportunities we offer. The majority of new cancer drugs approved for use in the U.S. in recent years were studied in clinical trials with FCS participation, prior to approval. Every interaction is focused on each patients experience and well-being to minimize disruption to daily life. Beginning with your first appointment, our dedicated FCS team provides expert guidance and support at every step of your cancer journey.

Care Philosophy: Dr Richard Levine is the Medical Director at Moffitt International Plaza (MIP). Dr Levine received his MD and MS in Pharmacology from Indiana University. He completed an internal medicine residency at the University of Cincinnati Medical Center and a medical oncology fellowship at the National Cancer Institute, Medical Branch. He joins Moffitt from Space Coast Cancer Center, where he served as President and founder. Dr Levine was the Chairman of the Cancer Committee and Tumor Board of Parrish Medical Center and Cape Canaveral Hospital for 25 years.

Biography: Dr. Satish Mahara is a Clinical Assistant Member in the Department of Satellite and Community Oncology. Dr. Maharaj received his MD degree from the University of the West Indies. He completed an Internal Medicine Residency at University of Florida Health, Jacksonville. He then completed a Hematology and Oncology Fellowship at the University of Louisville, Brown Cancer Center, Kentucky. Dr. Maharaj joins us from Texas Tech University, Paul L Foster School of Medicine, where he was an Assistant Professor and attending physician in Hematology and Oncology at the University Medical Center, El Paso. Dr. Maharaj's clinical focus is on the treatment of gastrointestinal and head and neck cancers, including oral cavity, oropharyngeal, esophageal, gastric, colorectal, liver, pancreatic, and anal cancers. His research focuses on investigating the use of various biomarkers to better classify, treat and monitor cancer and the potential adverse effects of therapy.

Care Philosophy: Dr Creelan earned his MD from Jefferson Medical College. He completed an Internal Medicine Residency at Thomas Jefferson University in the Department of Internal Medicine. Dr Creelan then completed a Hematology Oncology Fellowship at the University of South Florida at Moffitt Cancer Center anda Master's Degree in Clinical and Translational Research through the National Institute of Health K30-sponsored SPOR program. Dr Creelan will focus on translational and clinical research, specifically the development of new immune therapies, for the treatment of lung cancers. His research efforts aim to more effectively treat these cancers based on new insights into the biology of the disease.

Care Philosophy: Dr Shahzad was recruited to Moffitt Cancer Center in 2013 as a gynecologic oncologist in The Center for Women's Oncology. He completed his Gynecology Oncology fellowship training at the prestigious University of Wisconsin-Madison, School of Medicine and Public Health, alongside with PhD in endocrinology-reproductive physiology with special focus in cancer biology. Early in his career, he has rapidly distinguished himself as a future thought leader in the field.

Care Philosophy: Dr Heather Han is a Senior Member and Director of Clinical Research in the Department of Breast Oncology. Dr Han received her medical degree from Seoul National University College of Medicine in South Korea. Following her internship and residency in Internal Medicine at the Cleveland Clinic Foundation in Ohio, she completed the medical oncology and hematology fellowship at the University of Miami. She joined the faculty at Moffitt Cancer Center in the Department of Breast Oncology in 2008. Dr Han is the principal investigator of multiple clinical trials investigating novel therapies to improve the outcomes of patients of both early and advanced-stage breast cancer.